Castle Biosciences (NASDAQ:CSTL) and Seres Therapeutics (NASDAQ:MCRB) are both small-cap medical companies vying for investor attention. This analysis evaluates their relative strengths across several key factors,...
Castle Biosciences, Inc. has announced significant findings regarding its TissueCypher® Barrett’s Esophagus test, which offers crucial insights into patient risk that extend beyond traditional pathology. The...
